|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Histopathological alternations of deep dorsal penile vein in venognic impotence显示文摘 | Anafarta K Beduk Y Ulooglu O | 1992 | Eur Urol1992，21，： | 1 |
| 2 | Mi crovessel density as a prognostic marker in bladder carcinoma:correlation with tumor grade stage and prognosis显示文摘 | CANOGLU A GOGUS C BEDUK Y | 2004 | Int Urol Nephrol2004，36，： | 1 |
| 3 | Microvessel density as a prognostic marker in bladder carcinoma:correlation with tumor grade,stage and prognosis显示文摘 | Canoglu A Gogus C Beduk Y | 2004 | Int Urol Nephrol2004，36，3： | 1 |
| 4 | Role of radiotherapy in oligometastatic breast cancer:Review of the literature显示文摘Metastatic breast cancer has been historically considered as an incurable disease.Radiotherapy(RT)has been traditionally used for only palliation of the symptoms caused by metastatic lesions.However,in recent years the concept of oligometastatic disease has been introduced in Cancer Medicine as a clinical scenario with a limited number of metastases(≤5)and involved organs(≤2)with controlled primary tumor.The main hypothesis in oligometastatic disease is that locoregional treatment of primary tumor site and metastasis-directed therapies with surgery and/or RT may improve outcomes.Recent studies have shown that not all metastatic breast cancer patients have the same prognosis,and selected patients with good prognostic features as those younger than 55 years,hormone receptor-positive,limited bone or liver metastases,a low-grade tumor,good performance status,long disease-free interval(>12 mo),and good response to systemic therapy may provide maximum benefit from definitive treatment procedures to all disease sites.While retrospective and prospective studies on locoregional treatment in oligometastatic breast cancer demonstrated conflicting results,there is an increasing trend in favor of locoregional treatment.Currently,available data also demonstrated the improvements in survival with metastasisdirected therapy in oligometastatic breast cancer.The current review will discuss the concept of oligometastases and provide up-to-date information about the role of RT in oligometastatic breast cancer. | Caglayan Selenge Beduk Esen Melis Gultekin Ferah Yildiz | 2022 | World Journal of Clinical Oncology2022，13，1： | 1 |
| 5 | Microvessel density as a prognostic marker in bladder carcinoma:correlation with tumor grade,stage and prognosis显示文摘 | Canoglu A Gogus C Beduk Y | 2004 | Int Urol Nephrol2004，36，3： | 1 |
| 6 | Micro-vessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis 显示文摘 | Canoglu A Gogus C Beduk Y | 2009 | Int Urol Nephrol2009，36，3： | 1 |
| 7 | Isolated local recurrence of renal cell carcinoma after radical nephrectomy:experience with 10 cases显示文摘 | Gogus C Baltaci S Beduk Y | 2003 | Urology2003，61，5： | 1 |
| 8 | Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy:results of a prospective multicentre study by the Turkish Society of Urooncology显示文摘 | Baltaci S Adsan O Ugurlu O Aslan G Can C Gunaydin G Buyukalpelli R Elhan A H Beduk Y | | 0，，04： | 1 |
| 9 | Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis显示文摘 | Canoglu A Gogus C Beduk Y | 2004 | Int Urol and Nephrol2004，36，： | 1 |
| 10 | The significance of random bladder biopsies in superficial bladder cancer 显示文摘 | Gogus C Beduk Y Turkolmez K | 2002 | Int Urol Nephrol2002，34，1： | 1 |
| 11 | Activities of superoxide dismutase and glutathione peroxidase enzymes in cancerous and non-cancerous human kidney tissues 显示文摘 | Durak I Beduk Y Kavutcu M | 1997 | International Urology and Nephrology1997，29，1： | 1 |
| 12 | The prognostic value of pe-ripheral blood lymphocyte subsets inpatients with bladder carcino-ma treated using neoadjuvant M-VEC che mother apy显示文摘 | Soygur T Beduk Y Baltaci S | 1999 | BJUInt1999，84，： | 1 |
| 13 | The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy显示文摘 | Beduk Y Baltaci S | 1999 | BJU Int1999，84，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员